Counterfeit Drug Detection Device Market Size & Growth to 2034

Counterfeit Drug Detection Device Market Overview for 2024 to 2034

The counterfeit drug detection device market is anticipated to be worth US$ 1,167.7 million in 2024. The market is expected to grow at a steady rate over the period from 2024 to 2034, with a CAGR of 3.3%. By the end of the forecast period, the market value is predicted to hit US$ 1,615.6 million.

Attributes	Details
Counterfeit Drug Detection Device Market Value for 2024	US$ 1,167.7 million
Projected Market Value for 2034	US$ 1,615.6 million
Value-based CAGR of Market for 2024 to 2034	3.3%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Counterfeit Drug Detection Device Market Forecast

Growing concern over the risk of counterfeit drugs causing significant health defects is fueling the drug detection device market.
Technological innovation in counterfeit drug detection devices, such as holographic duplication, is advancing the demand in the market.
Increasing budgets of narcotics divisions of police is leading to greater adoption of counterfeit drug detection devices.
Artificial intelligence is being deployed to increase the accuracy of counterfeit drug detection, thus making the device more attractive.
Initiatives by governments to nullify the supply of counterfeited drugs are leading to wider adoption of counterfeited drug detection devices.

Counterfeit Drug Detection Device Market Trends

Portable counterfeit drug detection devices are increasing the accessibility of the device and leading to its greater adoption.
Counterfeit drug devices are seeing greater adoption as the checkpoints of drug testing are rising.
Counterfeit drug devices are being used both to scan for empty drugs and drugs with properties other than the ones promoted.
Increasing number of drug cartels and criminals who engage in drug counterfeit activities are necessitating the use of drug counterfeit devices.
Increasing functionality of counterfeit drug detection devices, through the medium of advanced scanning systems, is propelling the market.
Development of an increasing number of illegal drugs is seeing greater adoption of counterfeit drug detection devices.
Lack of centralized measures to stop the threat of counterfeit drugs in certain countries is hindering the growth of the market.
Lack of infrastructure to stop the influx of fake drugs in developing nations results in the market’s slow growth in these countries.

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Category-wise Outlook

Counterfeit chemical composition detection devices are firm in their position at the top of the product segment. Pharmaceutical companies are the predominant users of counterfeit drug detection devices.

High Accuracy Provided by Counterfeit Chemical Composition Detection Devices Sees them Grow Significantly in Demand

For 2024, counterfeit chemical composition detection devices are expected to account for 55.0% of the market share by product. Some of the key drivers for the increasing use of counterfeit chemical composition detection devices are:

Counterfeit chemical composition detection devices are trusted in their ability to sniff out the fake stuff and are thus continuing to be used by consumers.
Chemical components of counterfeit chemical composition detection devices are trusted to identify the active ingredients of drugs quicker and are thus preferred by consumers.

Attributes	Details
Top Product	Counterfeit Chemical Composition Detection Devices
Market Share (2024)	55.0%

Desire of Pharmaceutical Companies to Clamp Down on Reputation-Tanking Counterfeit Drugs Leads to Progress of the Market

Pharmaceutical industry use of counterfeit drug detection devices is anticipated to account for 37.8% of the market share in 2024. Some of the key drivers for the progress of counterfeit drug detection devices by pharmaceutical companies include:

Pharmaceutical companies are desirous to weed out any elements that damage their reputation and thus counterfeit drug detection devices are being used by them.
Increase in checkpoints established by drug detection companies is aiding the growth of the drug detection device market.

Attributes	Details
Top End User	Pharmaceutical Companies
Market Share (2024)	37.8%

Country-wise Analysis

Increasing governmental initiatives to curb counterfeit drugs are benefitting the market in the Asia Pacific. The rise in scams related to counterfeit drugs is also increasing the importance of the devices in the region.

Europe’s reputed security systems are integrating the device into their work, thus advancing the market’s prospects. The affluent pharmaceutical companies are also not hesitant to integrate the product into their work and thus the market is developing positively in the region.

Countries	CAGR
India	5.4%
Thailand	5.0%
Malaysia	3.8%
France	3.8%
Spain	4.0%

Rise in Duping Related to Counterfeit Drugs Catapulting the Market in the Region

The market is set to register a CAGR of 5.4% in India for the forecast period. The key drivers for growth are:

Rise in scams related to fake drugs is necessitating the use of counterfeit drug detection devices in India.
Shipping of illegal substances through the means of counterfeit drugs is being stopped in India with the help of counterfeit drug detection devices.

Threat of Health Hazards Drives Public and Private Sector Players to Adopt Counterfeit Drug Detection Devices in Thailand

The CAGR for counterfeit drug detection device in Thailand is tipped to be 5.0% over the forecast period. Some of the key factors driving the growth are:

Both public and private sector stakeholders in Thailand are looking to counter fake drugs and their potentially lethal effects. Thus, the devices are rising in popularity in Thailand.
Thailand’s high amount of tourists brings with it the danger of counterfeit drugs and thus the devices are increasingly being adopted in Thailand.

Malaysia’s Strict Actions to Counter Counterfeit Drug Supply Boosting the Market in the Country

The CAGR for counterfeit drug detection device in Malaysia is tipped to be 3.8% over the forecast period. Some of the key factors driving the growth are:

Malaysia has established strict measures to clamp down on illegal as well as counterfeit drugs. Thus, the use of the devices by the public sector research institutes is growing.
Technologically advanced counterfeit drug detection devices are seeing increasing adoption in Malaysia as the demand for accuracy gets significant in the country’s pharmaceutical sector.

Encouragement for Research Institutions Propelling the Market in France

The market is expected to register a CAGR of 3.8% in France for the forecast period. Some of the key trends include:

French research institutions are receiving funding from both private and public sources and thus drug detection devices are becoming more commonplace in these institutions.
Presence of reputed pharmaceutical companies in France sees the demand for the product increase in the country.

Technology Playing Key Role in Market’s Expansion in Spain

The market is expected to register a CAGR of 4.0% in Spain over the forecast period. Some of the key trends include:

Counterfeit drug detection devices with technology such as AI are being preferred in Spain and thus the market is experiencing growth in the country.
Increase in the number of drug testing laboratories is seeing the demand for the product increase in Spain.

Competitive Landscape in the Counterfeit Drug Detection Device Market

The counterfeit drug detection device market is fairly fragmented. While a few reputed companies have a significant share of the market demand, newer players and small-scale players also have the potential to thrive.

Technologically advancing the products, to keep the product line moving, is given priority by market players. Geographical expansion is also given significance by market players.

Recent Developments in the Counterfeit Drug Detection Device Market

In February 2022, the AD Minidose U9 RAIN RFID was launched by Avery Dennison Smartrac
for enhanced RFID applications in the healthcare sector.
In August 2021, Vestcom was acquired by Avery Dennison Corporation.
In December 2021, Stratio, Inc., with the help of South Korea's National IT Industry Promotion Agency (NIPA) launched an AI-enabled imaging solution. It is designed to detect infringements at border checkpoints.
In September 2021, the Fluoride ISE was introduced by Metrohm for the detection of, as the name suggests, fluoride.

Key Companies in the Counterfeit Drug Detection Device Market

Spectris
Spectral Engines Oy
Consumer Physics
Olympus Corporation
Stratio, Inc.
Rigaku Corporation
Thermo Fisher Scientific, Inc
GAO RFID
Cellular Bioengineering, Inc
Metrohm AG

Key Coverage in the Counterfeit Drug Detection Device Industry Report

Counterfeit Drug Device Market Size and Share Analysis
Counterfeit Drug Detection Device Market Forecast
growth analysis of the counterfeit drug detection device market
Sales Analysis Of Counterfeit Drug Detection Device Market
Counterfeit Drug Detection Device Industry Analysis
Counterfeit Drug Detection Device Share in Anti-counterfeiting Technology Industry Analysis

Key Segments

By Product:

Counterfeit Chemical Composition Detection Devices
- Ultraviolet/Vis Devices
- Infrared & Near Infrared Spectroscopy Device
- Raman Spectrometers
- XRD & XRF Spectroscopy Devices
Counterfeit Packaging & Labelling Detection Devices
- RFID Analyzer
- Scanning & Imaging Systems
- Others

By Modality:

Portable Devices
Hand-held Devices
Bench-top Devices

By End User:

Pharmaceutical Companies
Drug Testing Laboratories
Research Organization

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)

Frequently Asked Questions

How Big is the Counterfeit Drug Detection Device Market?

The counterfeit drug detection device market size is expected to be worth US$ 1,167.7 million in 2024.

How Big Will the Counterfeit Drug Detection Device Market Be in 2034?

The counterfeit drug detection device market is estimated to get as big as US$ 1,615.6 million in 2034.

How will the Counterfeit Drug Detection Device Market Progress in India?

The CAGR of the counterfeit drug detection device market during the 2024 to 2034 period in India is estimated to be 5.4%.

What are the Segments of the Counterfeit Drug Detection Device Market?

The counterfeit drug detection device market can be divided into the following segments: product, modality, and end user.

What is the Scope of the Counterfeit Drug Detection Device Market?

The counterfeit drug detection device market is expected to grow at a CAGR of 3.3% over the period of 2024 to 2034.

What are the Trends in the Counterfeit Drug Detection Device Industry?

Use of AI in the devices as well as advanced scanning systems are two of the trends in the counterfeit drug detection device industry.

How is the Counterfeit Drug Detection Device Market Forecasted to Grow in Thailand?

The counterfeit drug detection device market is forecasted to grow at a CAGR of 5.0% in Thailand over the period from 2024 to 2034.

Who are the Key Players in the Counterfeit Drug Detection Device Industry?

Spectris, Spectral Engines Oy, Consumer Physics, and Olympus Corporation are some of the key companies in the counterfeit drug detection device industry.

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

3.2.1. Demand in Optimistic Scenario

3.2.2. Demand in Likely Scenario

3.2.3. Demand in Conservative Scenario

3.3. Opportunity Map Analysis

3.4. Product Life Cycle Analysis

3.5. Supply Chain Analysis

3.5.1. Supply Side Participants and their Roles

3.5.1.1. Manufacturer

3.5.1.2. Mid-Level Participants (Traders)

3.5.1.3. Distributors

3.5.2. Value Added and Value Created at Node in the Supply Chain

3.5.3. List of Raw Material Suppliers

3.5.4. List of Existing and Potential Buyer’s

3.6. Investment Feasibility Matrix

3.7. Value Chain Analysis

3.7.1. Profit Margin Analysis

3.7.2. Distributors

3.8. PESTLE and Porter’s Analysis

3.9. Regulatory Landscape

3.9.1. By Key Regions

3.9.2. By Key Countries

3.10. Regional Parent Market Outlook

3.11. Production and Consumption Statistics

3.12. Import and Export Statistics

4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034

4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2019 to 2023

4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2024 to 2034

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product

5.1. Introduction / Key Findings

5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2019 to 2023

5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2024 to 2034

5.3.1. Counterfeit Chemical Composition Detection Devices

5.3.1.1. Ultraviolet/Vis Devices

5.3.1.2. Infrared & Near Infrared Spectroscopy Device

5.3.1.3. Raman Spectrometers

5.3.1.4. XRD & XRF Spectroscopy Devices

5.3.2. Counterfeit Packaging & Labelling Detection Devices

5.3.2.1. RFID Analyzer

5.3.2.2. Scanning & Imaging Systems

5.3.2.3. Others

5.4. Y-o-Y Growth Trend Analysis By Product, 2019 to 2023

5.5. Absolute $ Opportunity Analysis By Product, 2024 to 2034

6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Modality

6.1. Introduction / Key Findings

6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Modality, 2019 to 2023

6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Modality, 2024 to 2034

6.3.1. Portable Devices

6.3.2. Hand-Held Devices

6.3.3. Bench-Top Devices

6.4. Y-o-Y Growth Trend Analysis By Modality, 2019 to 2023

6.5. Absolute $ Opportunity Analysis By Modality, 2024 to 2034

7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User

7.1. Introduction / Key Findings

7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2019 to 2023

7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2024 to 2034

7.3.1. Pharmaceutical Companies

7.3.2. Drug Testing Laboratories

7.3.3. Research Organization

7.4. Y-o-Y Growth Trend Analysis By End User, 2019 to 2023

7.5. Absolute $ Opportunity Analysis By End User, 2024 to 2034

8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region

8.1. Introduction

8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2019 to 2023

8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2024 to 2034

8.3.1. North America

8.3.2. Latin America

8.3.3. Western Europe

8.3.4. Eastern Europe

8.3.5. South Asia and Pacific

8.3.6. East Asia

8.3.7. Middle East and Africa

8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

9.2.1. By Country

9.2.1.1. USA

9.2.1.2. Canada

9.2.2. By Product

9.2.3. By Modality

9.2.4. By End User

9.3. Market Attractiveness Analysis

9.3.1. By Country

9.3.2. By Product

9.3.3. By Modality

9.3.4. By End User

9.4. Key Takeaways

10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

10.2.1. By Country

10.2.1.1. Brazil

10.2.1.2. Mexico

10.2.1.3. Rest of Latin America

10.2.2. By Product

10.2.3. By Modality

10.2.4. By End User

10.3. Market Attractiveness Analysis

10.3.1. By Country

10.3.2. By Product

10.3.3. By Modality

10.3.4. By End User

10.4. Key Takeaways

11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

11.2.1. By Country

11.2.1.1. Germany

11.2.1.2. UK

11.2.1.3. France

11.2.1.4. Spain

11.2.1.5. Italy

11.2.1.6. Rest of Western Europe

11.2.2. By Product

11.2.3. By Modality

11.2.4. By End User

11.3. Market Attractiveness Analysis

11.3.1. By Country

11.3.2. By Product

11.3.3. By Modality

11.3.4. By End User

11.4. Key Takeaways

12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

12.2.1. By Country

12.2.1.1. Poland

12.2.1.2. Russia

12.2.1.3. Czech Republic

12.2.1.4. Romania

12.2.1.5. Rest of Eastern Europe

12.2.2. By Product

12.2.3. By Modality

12.2.4. By End User

12.3. Market Attractiveness Analysis

12.3.1. By Country

12.3.2. By Product

12.3.3. By Modality

12.3.4. By End User

12.4. Key Takeaways

13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

13.2.1. By Country

13.2.1.1. India

13.2.1.2. Bangladesh

13.2.1.3. Australia

13.2.1.4. New Zealand

13.2.1.5. Rest of South Asia and Pacific

13.2.2. By Product

13.2.3. By Modality

13.2.4. By End User

13.3. Market Attractiveness Analysis

13.3.1. By Country

13.3.2. By Product

13.3.3. By Modality

13.3.4. By End User

13.4. Key Takeaways

14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

14.2.1. By Country

14.2.1.1. China

14.2.1.2. Japan

14.2.1.3. South Korea

14.2.2. By Product

14.2.3. By Modality

14.2.4. By End User

14.3. Market Attractiveness Analysis

14.3.1. By Country

14.3.2. By Product

14.3.3. By Modality

14.3.4. By End User

14.4. Key Takeaways

15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

15.2.1. By Country

15.2.1.1. GCC Countries

15.2.1.2. South Africa

15.2.1.3. Israel

15.2.1.4. Rest of MEA

15.2.2. By Product

15.2.3. By Modality

15.2.4. By End User

15.3. Market Attractiveness Analysis

15.3.1. By Country

15.3.2. By Product

15.3.3. By Modality

15.3.4. By End User

15.4. Key Takeaways

16. Key Countries Market Analysis

16.1. USA

16.1.1. Pricing Analysis

16.1.2. Market Share Analysis, 2023

16.1.2.1. By Product

16.1.2.2. By Modality

16.1.2.3. By End User

16.2. Canada

16.2.1. Pricing Analysis

16.2.2. Market Share Analysis, 2023

16.2.2.1. By Product

16.2.2.2. By Modality

16.2.2.3. By End User

16.3. Brazil

16.3.1. Pricing Analysis

16.3.2. Market Share Analysis, 2023

16.3.2.1. By Product

16.3.2.2. By Modality

16.3.2.3. By End User

16.4. Mexico

16.4.1. Pricing Analysis

16.4.2. Market Share Analysis, 2023

16.4.2.1. By Product

16.4.2.2. By Modality

16.4.2.3. By End User

16.5. Germany

16.5.1. Pricing Analysis

16.5.2. Market Share Analysis, 2023

16.5.2.1. By Product

16.5.2.2. By Modality

16.5.2.3. By End User

16.6. UK

16.6.1. Pricing Analysis

16.6.2. Market Share Analysis, 2023

16.6.2.1. By Product

16.6.2.2. By Modality

16.6.2.3. By End User

16.7. France

16.7.1. Pricing Analysis

16.7.2. Market Share Analysis, 2023

16.7.2.1. By Product

16.7.2.2. By Modality

16.7.2.3. By End User

16.8. Spain

16.8.1. Pricing Analysis

16.8.2. Market Share Analysis, 2023

16.8.2.1. By Product

16.8.2.2. By Modality

16.8.2.3. By End User

16.9. Italy

16.9.1. Pricing Analysis

16.9.2. Market Share Analysis, 2023

16.9.2.1. By Product

16.9.2.2. By Modality

16.9.2.3. By End User

16.10. Poland

16.10.1. Pricing Analysis

16.10.2. Market Share Analysis, 2023

16.10.2.1. By Product

16.10.2.2. By Modality

16.10.2.3. By End User

16.11. Russia

16.11.1. Pricing Analysis

16.11.2. Market Share Analysis, 2023

16.11.2.1. By Product

16.11.2.2. By Modality

16.11.2.3. By End User

16.12. Czech Republic

16.12.1. Pricing Analysis

16.12.2. Market Share Analysis, 2023

16.12.2.1. By Product

16.12.2.2. By Modality

16.12.2.3. By End User

16.13. Romania

16.13.1. Pricing Analysis

16.13.2. Market Share Analysis, 2023

16.13.2.1. By Product

16.13.2.2. By Modality

16.13.2.3. By End User

16.14. India

16.14.1. Pricing Analysis

16.14.2. Market Share Analysis, 2023

16.14.2.1. By Product

16.14.2.2. By Modality

16.14.2.3. By End User

16.15. Bangladesh

16.15.1. Pricing Analysis

16.15.2. Market Share Analysis, 2023

16.15.2.1. By Product

16.15.2.2. By Modality

16.15.2.3. By End User

16.16. Australia

16.16.1. Pricing Analysis

16.16.2. Market Share Analysis, 2023

16.16.2.1. By Product

16.16.2.2. By Modality

16.16.2.3. By End User

16.17. New Zealand

16.17.1. Pricing Analysis

16.17.2. Market Share Analysis, 2023

16.17.2.1. By Product

16.17.2.2. By Modality

16.17.2.3. By End User

16.18. China

16.18.1. Pricing Analysis

16.18.2. Market Share Analysis, 2023

16.18.2.1. By Product

16.18.2.2. By Modality

16.18.2.3. By End User

16.19. Japan

16.19.1. Pricing Analysis

16.19.2. Market Share Analysis, 2023

16.19.2.1. By Product

16.19.2.2. By Modality

16.19.2.3. By End User

16.20. South Korea

16.20.1. Pricing Analysis

16.20.2. Market Share Analysis, 2023

16.20.2.1. By Product

16.20.2.2. By Modality

16.20.2.3. By End User

16.21. GCC Countries

16.21.1. Pricing Analysis

16.21.2. Market Share Analysis, 2023

16.21.2.1. By Product

16.21.2.2. By Modality

16.21.2.3. By End User

16.22. South Africa

16.22.1. Pricing Analysis

16.22.2. Market Share Analysis, 2023

16.22.2.1. By Product

16.22.2.2. By Modality

16.22.2.3. By End User

16.23. Israel

16.23.1. Pricing Analysis

16.23.2. Market Share Analysis, 2023

16.23.2.1. By Product

16.23.2.2. By Modality

16.23.2.3. By End User

17. Market Structure Analysis

17.1. Competition Dashboard

17.2. Competition Benchmarking

17.3. Market Share Analysis of Top Players

17.3.1. By Regional

17.3.2. By Product

17.3.3. By Modality

17.3.4. By End User

18. Competition Analysis

18.1. Competition Deep Dive

18.1.1. Spectris

18.1.1.1. Overview

18.1.1.2. Product Portfolio

18.1.1.3. Profitability by Market Segments

18.1.1.4. Sales Footprint

18.1.1.5. Strategy Overview

18.1.1.5.1. Marketing Strategy

18.1.1.5.2. Product Strategy

18.1.1.5.3. Channel Strategy

18.1.2. Spectral Engines Oy

18.1.2.1. Overview

18.1.2.2. Product Portfolio

18.1.2.3. Profitability by Market Segments

18.1.2.4. Sales Footprint

18.1.2.5. Strategy Overview

18.1.2.5.1. Marketing Strategy

18.1.2.5.2. Product Strategy

18.1.2.5.3. Channel Strategy

18.1.3. Consumer Physics

18.1.3.1. Overview

18.1.3.2. Product Portfolio

18.1.3.3. Profitability by Market Segments

18.1.3.4. Sales Footprint

18.1.3.5. Strategy Overview

18.1.3.5.1. Marketing Strategy

18.1.3.5.2. Product Strategy

18.1.3.5.3. Channel Strategy

18.1.4. Olympus Corporation

18.1.4.1. Overview

18.1.4.2. Product Portfolio

18.1.4.3. Profitability by Market Segments

18.1.4.4. Sales Footprint

18.1.4.5. Strategy Overview

18.1.4.5.1. Marketing Strategy

18.1.4.5.2. Product Strategy

18.1.4.5.3. Channel Strategy

18.1.5. Stratio, Inc.

18.1.5.1. Overview

18.1.5.2. Product Portfolio

18.1.5.3. Profitability by Market Segments

18.1.5.4. Sales Footprint

18.1.5.5. Strategy Overview

18.1.5.5.1. Marketing Strategy

18.1.5.5.2. Product Strategy

18.1.5.5.3. Channel Strategy

18.1.6. Rigaku Corporation

18.1.6.1. Overview

18.1.6.2. Product Portfolio

18.1.6.3. Profitability by Market Segments

18.1.6.4. Sales Footprint

18.1.6.5. Strategy Overview

18.1.6.5.1. Marketing Strategy

18.1.6.5.2. Product Strategy

18.1.6.5.3. Channel Strategy

18.1.7. Thermo Fisher Scientific, Inc

18.1.7.1. Overview

18.1.7.2. Product Portfolio

18.1.7.3. Profitability by Market Segments

18.1.7.4. Sales Footprint

18.1.7.5. Strategy Overview

18.1.7.5.1. Marketing Strategy

18.1.7.5.2. Product Strategy

18.1.7.5.3. Channel Strategy

18.1.8. GAO RFID

18.1.8.1. Overview

18.1.8.2. Product Portfolio

18.1.8.3. Profitability by Market Segments

18.1.8.4. Sales Footprint

18.1.8.5. Strategy Overview

18.1.8.5.1. Marketing Strategy

18.1.8.5.2. Product Strategy

18.1.8.5.3. Channel Strategy

18.1.9. Cellular Bioengineering, Inc

18.1.9.1. Overview

18.1.9.2. Product Portfolio

18.1.9.3. Profitability by Market Segments

18.1.9.4. Sales Footprint

18.1.9.5. Strategy Overview

18.1.9.5.1. Marketing Strategy

18.1.9.5.2. Product Strategy

18.1.9.5.3. Channel Strategy

18.1.10. Metrohm AG

18.1.10.1. Overview

18.1.10.2. Product Portfolio

18.1.10.3. Profitability by Market Segments

18.1.10.4. Sales Footprint

18.1.10.5. Strategy Overview

18.1.10.5.1. Marketing Strategy

18.1.10.5.2. Product Strategy

18.1.10.5.3. Channel Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Counterfeit Drug Detection Device Market

A Study of the Counterfeit Drug Detection Device Market by Counterfeit Chemical Composition Detection Devices and Counterfeit Packaging and Labelling Detection Devices